Synlogic

Synlogic is a biotechnology company that focuses on developing innovative therapies using synthetic biology. Its approach involves engineering bacteria to act as living medicines that can target and treat diseases, particularly metabolic disorders. By modifying these microorganisms, Synlogic aims to create treatments that can be taken orally and have the ability to restore normal biological functions in the body. This technology holds potential for more effective and tailored treatments for conditions that currently have limited options.